Neuropharmacology & Neurotherapeutics
Anti-CGRP monoclonal antibodies for prevention of migraine
Mar. 24, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Because the SNc projects to the striatum as well as to the GPi, GPe, STN, and SNr (not depicted in diagram), dopaminergic deficits disrupt communication of the entire basal ganglia network. The reduction of striatal dopamine is positively correlated to the degree of cell loss in the SNc. (Contributed by Dr. Rita Tranquilli.)